CRN Welcomes FDA's Proposed NAC Rule, Urges Broader Clarification of Drug Preclusion Framework
November 16, 2026 — The Council for Responsible Nutrition (CRN), the leading trade association representing the dietary supplement and functional food industry, today welcomed the U.S. Food and Drug Administration's (FDA) proposed rule that would allow N-acetyl-L-cysteine (NAC) to be marketed in dietary supplements, and establish a regulatory list of ingredients exempted from drug preclusion. However, CRN emphasized that the proposal falls short of providing a clear process for other ingredients to be added to the list and leaves broader questions about the drug preclusion framework unresolved
